Similar articles

• A 25-year review of sequential methodology in clinical studies.

  Todd S. Todd S. Stat Med. 2007 Jan 30;26(2):237-52. doi: 10.1002/sim.2763. Stat Med. 2007. PMID: 17139691 Review.
• [Methodological approaches of clinical studies with targeted therapies].

  Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J. Penel N, et al. Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Review. French.
• Re: Design and endpoints of clinical trials in hepatocellular carcinoma.

  Di Maio M, Daniele B, Gallo C, Perrone F. Di Maio M, et al. J Natl Cancer Inst. 2008 Nov 5;100(21):1557; author reply 1557-8. doi: 10.1093/jnci/djn341. Epub 2008 Oct 28. J Natl Cancer Inst. 2008. PMID: 18957679 No abstract available.
• An overview of clinical trials.

  Rich K. Rich K. J Vasc Nurs. 2004 Mar;22(1):32-4. doi: 10.1016/s1062-0303(03)00116-x. J Vasc Nurs. 2004. PMID: 14981501 Review. No abstract available.
• A strategic framework for novel drug development in multiple myeloma.

  Anderson KC, Hannah AL, Pazdur R, Farrell AT. Anderson KC, et al. Br J Haematol. 2007 Jul;138(2):153-9. doi: 10.1111/j.1365-2141.2007.06641.x. Br J Haematol. 2007. PMID: 17593022 Review. No abstract available.